Policy

In October 2014, IAPO Policy Manager Alison Lightbourne attended a meeting to discuss health technology assessment (HTA) and how it will help or limit patient access to new medicines and treatment. HTA is quickly evolving into a global issue and is now featured within the World Health Organisation...

Jolanta Bilinska, IAPO Chair Elect, and Evgenia Starkova, from IAPO member Together Against Cancer, attended the WHO Regional Committee meeting for Europe in Copenhagen, Denmark from 15 to 18 September 2014. In what ways did you represent IAPO at your WHO Regional Committee? We shared two...

Las Reuniones del Comité Regional 2014 de la Organización Mundial de la Salud (OMS) 2014 están en marcha. Estas buscan fijar políticas, aprobar presupuestos y decidir los programas de trabajo para cada una de las regiones de la OMS.. Representantes de IAPO asistieron las semanas anteriores a...

IAPO Governing Board Member Eva Maria Ruiz de Castilla recently attended two UN meetings on non-communicable diseases (NCDs). An informal interactive meeting for civil society was held on 19 June 2014 to discuss progress in NCD work since 2011 and to identify priorities going forward.

IAPO member Theobald Hepatitis B Foundation, along with partners, offered free hepatitis B screening and vaccination to hundreds of people at James Town – Mantse Abgona in Accra, Ghana, on 26 July 2014.

In June 2014, our Senior Policy Officer Rachel Seal-Jones spoke to new IAPO member Powerful Patient through a podcast. Powerful Patient is based in the United States and works to empower people living with chronic diseases or disabilities.

Tuesday 21st January 2014 - 134th Session of the World Health Organization's Executive Board, Geneva. IAPO delivered an intervention on Agenda Item 7.1: Follow up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. IAPO called on Member States to develop national action plans to ensure that progress is sustained at the national level, as well as highlighting the importance of patients being at the centre of all NCD strategies.